Ignite Creation Date:
2025-12-25 @ 2:28 AM
Ignite Modification Date:
2026-01-08 @ 6:00 PM
Study NCT ID:
NCT00773734
Status:
COMPLETED
Last Update Posted:
2020-05-07
First Post:
2008-10-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
Sponsor:
Amgen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-09-01
Start Date Type:
ACTUAL
Primary Completion Date:
2009-08-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-05-20
Completion Date Type:
ACTUAL
First Submit Date:
2008-10-14
First Submit QC Date:
None
Study First Post Date:
2008-10-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-10-22
Results First Submit QC Date:
None
Results First Post Date:
2014-11-13
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2013-08-02
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2020-04-22
Last Update Post Date:
2020-05-07
Last Update Post Date Type:
ACTUAL